Rhumbline Advisers Lowers Stock Holdings in Molina Healthcare, Inc $MOH

Rhumbline Advisers cut its holdings in Molina Healthcare, Inc (NYSE:MOH) by 3.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 141,546 shares of the company’s stock after selling 5,288 shares during the period. Rhumbline Advisers’ holdings in Molina Healthcare were worth $42,166,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its holdings in shares of Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. AQR Capital Management LLC lifted its position in Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock worth $288,125,000 after buying an additional 264,664 shares during the period. Fiera Capital Corp acquired a new stake in Molina Healthcare in the 2nd quarter worth about $42,644,000. Nuveen LLC purchased a new stake in Molina Healthcare in the 1st quarter valued at about $46,441,000. Finally, T. Rowe Price Investment Management Inc. grew its holdings in Molina Healthcare by 8.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock valued at $490,099,000 after buying an additional 117,796 shares during the period. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on MOH shares. Deutsche Bank Aktiengesellschaft set a $165.00 target price on shares of Molina Healthcare in a research report on Friday, October 24th. Wall Street Zen downgraded shares of Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Saturday, October 25th. Barclays reissued an “underweight” rating and set a $144.00 price objective (down from $185.00) on shares of Molina Healthcare in a research note on Friday, October 24th. UBS Group cut their target price on Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating on the stock in a research report on Friday, October 24th. Finally, The Goldman Sachs Group reduced their target price on Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a report on Friday, October 24th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $198.93.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the sale, the director owned 11,352 shares in the company, valued at approximately $1,623,563.04. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.10% of the stock is owned by insiders.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $145.29 on Tuesday. The firm has a fifty day moving average of $171.42 and a 200-day moving average of $210.87. Molina Healthcare, Inc has a 52-week low of $133.40 and a 52-week high of $359.97. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $7.87 billion, a P/E ratio of 9.00 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a return on equity of 22.95% and a net margin of 1.98%.The business had revenue of $11.48 billion for the quarter, compared to analysts’ expectations of $10.99 billion. During the same period last year, the company posted $6.01 earnings per share. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.